Drug
Bay3389934
Bay3389934: highest development phase Phase 1, developed by Bayer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Bayer
Trials
| Drug | Phase | Indication |
|---|---|---|
| BAY3389934 NCT06854640 | Phase 1 | Sepsis |
Latest
No recent events.
Follow Bay3389934 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.